Community post

The FDA approved Rebyota, the first fecal microbiota product, for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older. Rebyota is administered rectally as a single dose and is prepared from stool donated by qualified individuals.